Akèy › Kansè lestomak › Kalifòni › Mountain View
Etid klinik pou Kansè lestomak nan Mountain View, CA
12 etid pou Kansè lestomak ap chèche patisipan nan sit nan ak bò kote Mountain View (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Ap rekriteFaz 2
- Research Site, Palo Alto · 5 mi lwen
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Ap rekriteFaz 1
- Stanford University Medical Center, Stanford · 5 mi lwen
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Ap rekriteFaz 1
- Stanford University Medical Center, Stanford · 5 mi lwen
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
- Stanford Cancer Institute, Stanford · 5 mi lwen
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Ap rekriteFaz 1
- Stanford Cancer Center, Palo Alto · 5 mi lwen
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.
Ap rekriteFaz 3
- Stanford University, Stanford · 5 mi lwen
The Gastric Cancer Foundation: A Gastric Cancer Registry
Ap rekriteEtid obsèvasyon
- Stanford University, School of Medicine, Stanford · 5 mi lwen
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
Ap rekriteEtid obsèvasyon
- Stanford University School of Medicine, Stanford · 5 mi lwen
The GAstric Precancerous Conditions Study
Ap rekriteEtid obsèvasyon
- Stanford University, Stanford · 5 mi lwen
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Stanford · 5 mi lwen
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Ap rekriteFaz 1/2
- Stanford Hospital & Clinics, Stanford · 5 mi lwen
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1
- Stanford University, Stanford · 5 mi lwen
Etid Kansè lestomak nan lòt vil
- Houston, TX42 etid
- Boston, MA32 etid
- New York City, NY31 etid
- Nashville, TN28 etid
- Baldwin Park, CA22 etid
- Los Angeles, CA22 etid
- Arlington, VA20 etid
- Dallas, TX19 etid
- San Antonio, TX19 etid
- Grand Rapids, MI18 etid
- St. Louis, MO18 etid
- Washington, DC16 etid
Lòt etid nan Mountain View
- Kansè (tout kalite)40 etid
- Kansè nan tete26 etid
- Kansè Metastatik25 etid
- Kansè Poumon ki pa ti selil21 etid
- Leksemi mieloïd egi19 etid
- Kansè ovè19 etid
- Twoub Spektòm Otis17 etid
- Kansè poumon17 etid
- Kansè pwostat15 etid
- Ensifizyans kadyak15 etid
- Otis13 etid
- Leksemi limfoblastik egi13 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.